Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program StudyZijun Y. Xu‐Monette, Ken H. Young, Youli Zu et al.|Blood|2012Cited by 390
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibitionJan A. Burger, Catherine J. Wu, Dan A. Landau et al.|Nature Communications|2016Cited by 346
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndromeSheng Xiao, Jonathan A. Fletcher, Srinivasa Nalabolu et al.|Nature Genetics|1998Cited by 327
Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classificationRobert P. Hasserjian, Sa A. Wang, Zhuang Zuo et al.|Blood|2009Cited by 108
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinibAdam S. Kittai, Jennifer A. Woyach, Cecelia Miller et al.|Blood|2021Cited by 61